The WHO pointers stipulate that manufacturers ought to build and adhere to specific routine maintenance schedules depending on machines specifications and use styles. Manufacturers wanting to apply these approaches will have to provide robust validation facts to demonstrate their equivalence to pharmacopoeial approaches. Whether it is a question of waiting for link from Forum Profiles (11)